Showing results (121-130 of 153) with videos related to
Sort By:
Pageof 16
Cancer|September 2, 2020
Phase 1 study of the immunotoxin LMB-100 in patients with mesothelioma and other solid tumors expressing mesothelinRaffit Hassan, Christine Alewine, Idrees Mian, et al.Frontiers in Oncology|May 6, 2024
Tofacitinib to prevent anti-drug antibody formation against LMB-100 immunotoxin in patients with advanced mesothelin-expressing cancersNebojsa Skorupan, Cody J Peer, Xianyu Zhang, et al.Neuro-Oncology|August 1, 2023
Phase I trial of panobinostat in children with diffuse intrinsic pontine glioma: A report from the Pediatric Brain Tumor Consortium (PBTC-047)Michelle Monje, Tabitha Cooney, John Glod, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 7, 2012
Sorafenib is an inhibitor of UGT1A1 but is metabolized by UGT1A9: implications of genetic variants on pharmacokinetics and hyperbilirubinemiaCody J Peer, Tristan M Sissung, Aerang Kim, et al.The Journal of Clinical Investigation|June 26, 2018
HSD3B1(1245A>C) variant regulates dueling abiraterone metabolite effects in prostate cancerMohammad Alyamani, Hamid Emamekhoo, Sunho Park, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 5, 2017
Safety and Clinical Activity of the Programmed Death-Ligand 1 Inhibitor Durvalumab in Combination With Poly (ADP-Ribose) Polymerase Inhibitor Olaparib or Vascular Endothelial Growth Factor Receptor 1-3 Inhibitor Cediranib in Women's Cancers: A Dose-Escalation, Phase I StudyJung-Min Lee, Ashley Cimino-Mathews, Cody J Peer, et al.Frontiers in Cell and Developmental Biology|November 8, 2024
Treatment with novel topoisomerase inhibitors in Ewing sarcoma models reveals heterogeneity of tumor responseUnsun Lee, Ludmila Szabova, Victor J Collins, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2017
Phase I and Preliminary Phase II Study of TRC105 in Combination with Sorafenib in Hepatocellular CarcinomaAustin G Duffy, Chi Ma, Susanna V Ulahannan, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2019
IL15 by Continuous Intravenous Infusion to Adult Patients with Solid Tumors in a Phase I Trial Induced Dramatic NK-Cell Subset ExpansionKevin C Conlon, E Lake Potter, Stefania Pittaluga, et al.Blood|March 1, 2011
Phase 2 trial of romidepsin in patients with peripheral T-cell lymphomaRichard L Piekarz, Robin Frye, H Miles Prince, et al.Pageof 16